Amendment AGREEMENTSecurities Purchase Agreement • October 17th, 2024 • Petros Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment Agreement (this “Agreement”), dated as of October 11, 2024, is by and between Petros Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each investor listed on the signature pages attached hereto (each an “Investor,” and collectively, the “Investors”).
